TRT side effects: Can supplements replace real medical management?
Quick answer
TRT-associated polycythemia is a well-documented adverse effect driven by testosterone's stimulation of erythropoiesis, with hematocrit exceeding 54% flagged as a threshold for intervention in Endocrine Society clinical guidelines. Blood pressure elevation on TRT is a separate but related concern, with evidence linking exogenous testosterone to modest increases in systolic pressure, particularly with intramuscular formulations. Neither condition has established over-the-counter supplement-based treatments, and both carry meaningful cardiovascular risk if left unmanaged through evidence-backed clinical strategies.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @aresnutrition actually say?
The creator's core argument is that when TRT causes elevated hematocrit or blood pressure, doctors only offer two options: phlebotomy or pulling you off testosterone. His proposed alternative is a supplement stack, specifically a product called Hemoflow and a nitric oxide-based blood pressure supplement he calls "Revive Blood P." He frames these as natural solutions that let patients "stay on TRT" without medical intervention.
To his credit, he does not claim these supplements cure anything outright. But the framing is pointed: doctors "don't have a natural solution," so try these products instead. That is a meaningful implication with real clinical consequences, and it deserves a closer look.
Does the science back this up?
Partially, and only for the nitric oxide angle. The claim that elevated hematocrit is a common TRT complication is well-supported. A 2017 meta-analysis by Fernandez-Balsells et al. in the Annals of Internal Medicine confirmed polycythemia as one of the more consistent adverse effects of testosterone therapy. On that point, the creator is not wrong.
The nitric oxide piece has some legitimate footing too. L-arginine and L-citrulline, common ingredients in "NO pump" products, have shown modest blood pressure-lowering effects in clinical trials. A 2019 review by Barkhidarian et al. in Nutrients found L-citrulline supplementation reduced systolic blood pressure by roughly 4 mmHg on average, which is real but modest. Whether that effect translates meaningfully in the context of TRT-induced hypertension is a different, unanswered question.
For hematocrit specifically, the evidence that any over-the-counter supplement reliably reduces elevated red blood cell mass is thin to nonexistent. Phlebotomy and dose reduction remain the evidence-backed options here per the Endocrine Society's 2018 clinical practice guidelines.
What did they get wrong (or right)?
Wrong: The assertion that doctors have no tools besides "dumping blood" or discontinuation is an overstatement. Dose reduction, switching delivery method (gels tend to produce lower hematocrit than injections per Coviello et al., 2008, JCEM), or adjusting injection frequency are all legitimate clinical levers. Patients deserve to know those options exist before turning to supplements.
Also wrong: Conflating blood pressure management with hematocrit management as though they are the same problem with the same solution. They are related but distinct issues. Nitric oxide donors do not lower hematocrit. The creator appears to blur this distinction when he says Hemoflow "supports hematocrit issues and also supports the thickening that's happening in your vessels," which mixes mechanisms in a way that is not scientifically coherent.
Right: The general principle that nitric oxide pathway support can assist with vascular tone is biologically sound. And he is correct that many patients do not want to discontinue TRT, which is a real and valid concern worth addressing with a physician rather than a supplement stack.
What should you actually know?
Elevated hematocrit on TRT, typically defined as a hematocrit above 54% per Endocrine Society guidelines, is not a nuisance side effect. It increases blood viscosity and raises the risk of thrombotic events including stroke and pulmonary embolism. This is not a situation where the stakes are low enough to experiment with unregulated supplements instead of having a direct conversation with your prescriber.
If your TRT provider's only tools are phlebotomy or discontinuation, that may reflect the limits of that particular provider, not the limits of medicine. A specialist in men's health or endocrinology has more options. Seeking a second clinical opinion is a more appropriate first step than buying a supplement stack from the same brand as the person giving advice on TikTok.
Nitric oxide supplements are not dangerous for most people, but they are not a validated substitute for managing TRT-related polycythemia. If you are experiencing elevated hematocrit or blood pressure on TRT, that warrants a lab review and a clinical conversation, not a new product in your stack.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT side effects: Can supplements replace real medical management?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT side effects: Can supplements replace real medical management? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
TRT-associated polycythemia is a well-documented adverse effect driven by testosterone's stimulation of erythropoiesis, with hematocrit exceeding 54% flagged as a threshold for intervention in Endocrine Society clinical guidelines.
FormBlends verdict
TRT-associated polycythemia is a well-documented adverse effect driven by testosterone's stimulation of erythropoiesis, with hematocrit exceeding 54% flagged as a threshold for intervention in Endocrine Society clinical guidelines. Blood pressure elevation on TRT is a separate but related concern, with evidence linking exogenous testosterone to modest increases in systolic pressure, particularly with intramuscular formulations. Neither condition has established over-the-counter supplement-based treatments, and both carry meaningful cardiovascular risk if left unmanaged through evidence-backed clinical strategies.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- TRT-associated polycythemia is a well-documented adverse effect driven by testosterone's stimulation of erythropoiesis, with hematocrit exceeding 54% flagged as a threshold for intervention in Endocrine Society clinical guidelines. Blood pressure elevation on TRT is a separate but related concern, with evidence linking exogenous testosterone to modest increases in systolic pressure, particularly with intramuscular formulations. Neither condition has established over-the-counter supplement-based treatments, and both carry meaningful cardiovascular risk if left unmanaged through evidence-backed clinical strategies.
- Hematocrit above 54% on TRT is an Endocrine Society-defined threshold for intervention due to increased thrombotic risk, not a side effect to self-manage with supplements.
- A 2010 meta-analysis (Fernandez-Balsells, Annals of Internal Medicine) confirmed polycythemia as one of the most common documented adverse effects of exogenous testosterone.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Hematocrit above 54% on TRT is an Endocrine Society-defined threshold for intervention due to increased thrombotic risk, not a side effect to self-manage with supplements.
- A 2010 meta-analysis (Fernandez-Balsells, Annals of Internal Medicine) confirmed polycythemia as one of the most common documented adverse effects of exogenous testosterone.
- Dose reduction and switching from injectable to topical testosterone formulations are evidence-backed strategies for reducing hematocrit; Coviello et al. (2008, JCEM) showed lower erythrocytosis rates with transdermal delivery.
- L-citrulline supplementation reduced systolic blood pressure by roughly 4 mmHg on average in a 2019 Nutrients review (Barkhidarian et al.), a real but modest effect with no TRT-specific trial data.
- No peer-reviewed clinical trial has evaluated Hemoflow or any comparable OTC supplement as a treatment for TRT-induced polycythemia.
- If your current TRT provider offers only phlebotomy or discontinuation, a second opinion from a men's health specialist or endocrinologist is a more appropriate next step than a supplement stack.
- Nitric oxide supplements and hematocrit management address different physiological problems; conflating the two misrepresents how each issue works mechanically.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Ares Nutrition · TikTok creator
214.5K views on this video
Replying to @Commoner side effects from TrT are def a issue where the dr wants to pull you off because they don’t have a solution besides writing you a script or pulling you off #aresnutrition #aresknowledge #tiktokshopping #tiktokshop #bodybuilding #hemoflow #bloodflow #bloodpressure
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Ares Nutrition, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.